1934
DOI: 10.1177/003591573402700315
|View full text |Cite
|
Sign up to set email alerts
|

Abdominal Carcinomatosis Associated with Vasomotor Disturbances

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0
2

Year Published

1958
1958
2010
2010

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(4 citation statements)
references
References 0 publications
0
2
0
2
Order By: Relevance
“…The recognition of carcinoids as endocrine-related tumors was outlined by Gosset and Masson 6 and the malignant carcinoid syndrome was first described by Cassidy. 7 Carcinoid tumors belong to a more general category of tumors called the APUDomas (i.e., amine precursor uptake and decarboxylation tumors). They develop in the Kulchitsky enterochromaffin cells in the crypts of Lieberkuhn and are characterized by the presence of neurosecretory granules.…”
Section: Discussionmentioning
confidence: 99%
“…The recognition of carcinoids as endocrine-related tumors was outlined by Gosset and Masson 6 and the malignant carcinoid syndrome was first described by Cassidy. 7 Carcinoid tumors belong to a more general category of tumors called the APUDomas (i.e., amine precursor uptake and decarboxylation tumors). They develop in the Kulchitsky enterochromaffin cells in the crypts of Lieberkuhn and are characterized by the presence of neurosecretory granules.…”
Section: Discussionmentioning
confidence: 99%
“…Gastrointestinal carcinoid was first described in 1888 [4]. Carcinoids tumors, initially regarded as benign [7], were refuted when the first case of malignant carcinoid syndrome surfaced in 1934 [8]. Carcinoids tumors, initially regarded as benign [7], were refuted when the first case of malignant carcinoid syndrome surfaced in 1934 [8].…”
Section: Introductionmentioning
confidence: 99%
“…Die Namensgebung geht auf Oberndorfer [44] zuru Èck, und 1934 wurde die maligne Variante entdeckt [14]. Erst 1953 wurde das Peptidhormon Serotonin in Karzinoidgewebe nachgewiesen [30], das ein Jahr spa Èter mit dem klinischen ¹Karzinoid-Syndromª in Zusammenhang gebracht wurde [16,55].…”
Section: Schlu è Sselwo èRter: Gastrointestinale Neuroendokrine Tumorunclassified